RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of ...

As 2024 concludes, here are 6 significant scientific discoveries, including medical breakthroughs, space exploration, and ...

Psychedelic industry faced setbacks, cannabis was almost rescheduled and overdose deaths dropped — but not for all ...

GILD has put up a steady performance in 2024, with a new drug approval, positive data readouts and strong quarterly results.

Lenacapavir is an innovative long-acting injectable for HIV pre-exposure prophylaxis (PrEP) that offers an unprecedented six ...

There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.

A claim circulating online falsely asserts the existence of a groundbreaking AIDS cure costing $40,000 annually.

Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...

As the year winds down, we wanted to take a look back at some of the top scientific discoveries that happened in 2024. From ...

Prioritizing disease prevention naturally requires implementing effective immunization campaigns while also fostering an ...

Investors are bullish on Gilead as the stock surges on successful launches and strong financial health, offering potential ...